Dr. Ali-Reza Sharif-Afshar, MD

Dr. Sharif-Afshar practices at Precision Ambulatory Surgery Center - Beverly Hills in Beverly Hills, California.

Dr. Sharif-Afshar's NPI, 1619315108, was assigned on June 6, 2013. Dr. Sharif-Afshar graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2011. Dr. Sharif-Afshar holds California license A125622.

Dr. Sharif-Afshar's primary practice is Precision Ambulatory Surgery Center - Beverly Hills, at 450 North Roxbury Drive, Suite 250, Beverly Hills, CA 90210. The practice phone is (310) 651-2040.

Dr. Sharif-Afshar's primary practice is Precision Ambulatory Surgery Center - Beverly Hills in Beverly Hills, California. Dr. Sharif-Afshar is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Saint John's Physician Partners. Dmand AI also links Dr. Sharif-Afshar to 2 more hospitals, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharif-Afshar practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sharif-Afshar's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Sharif-Afshar is board certified in urology by the American Board of Urology. Dmand AI has Dr. Sharif-Afshar's licenses on file in 8 states: California, Massachusetts, Hawaii, Michigan, Maryland, Ohio, Oklahoma and South Carolina.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Sharif-Afshar treats.

CMS data shows 4,499 Medicare services from Dr. Sharif-Afshar across 33 procedure codes in 2024, for 681 Medicare patients. Medicare paid $281,959 for them.

CMS counts 681 Medicare patients who saw Dr. Sharif-Afshar in 2024. The largest group is 65 to 74, with 317 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sharif-Afshar's median patient age at 70, with 16% women.

In 2024, Dr. Sharif-Afshar wrote 1,647 Medicare Part D claims for 442 patients. 87% of them were for generic drugs. CMS names the drug for 1,513 of them, across 22 drugs with 11 or more claims each, at $184,838 in total drug cost. In 2023, CMS named 1,908 claims across 29 drugs.

Dr. Sharif-Afshar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of prostate resection by Dr. Sharif-Afshar, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Sharif-Afshar, published from 2007 to 2024. 2007 was the busiest year, with 2. The most frequent topics are Urinary Bladder, Embryonic Stem Cells and Hepatocyte Nuclear Factor 3-alpha. Dr. Sharif-Afshar's most frequent co-authors are Mark Adams, MD, Jennifer T. Anger, MD and Romano T. Demarco, MD.

Dmand AI links Dr. Sharif-Afshar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 439 general payments to Dr. Sharif-Afshar from 44 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 31% of the total. PROCEPT BioRobotics Corporation paid the most, $44,354.

Dr. Sharif-Afshar graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2011.

Dr. Sharif-Afshar is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.